Skip to main content
AMN
NYSE Trade & Services

AMN Healthcare Reports Continued Net Loss and $109.5M Goodwill Impairment in 2025 Annual Filing

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$17.85
Mkt Cap
$663.79M
52W Low
$14.865
52W High
$30.49
Market data snapshot near publication time

summarizeSummary

AMN Healthcare Services, Inc. reported a net loss of $95.7 million for fiscal year 2025, alongside a significant $109.5 million goodwill impairment, reflecting ongoing revenue declines and operational challenges in its healthcare staffing segments.


check_boxKey Events

  • Full Year Net Loss Reported

    The company reported a net loss of $95.7 million for fiscal year 2025, marking a second consecutive year of unprofitability, though the loss narrowed from $147.0 million in 2024.

  • Significant Goodwill Impairment

    A $109.5 million goodwill impairment loss was recognized in the Physician and Leadership Solutions segment, indicating underperformance of acquired assets.

  • Revenue Decline Continues

    Consolidated revenue decreased by 8% to $2.73 billion in 2025 from $2.98 billion in 2024, primarily due to lower demand in the nurse and allied solutions segment.

  • Debt Refinancing at Higher Rate

    The company redeemed $500 million of 4.625% senior notes due 2027 and issued $400 million of new 6.500% senior notes due 2031, leading to increased interest costs.


auto_awesomeAnalysis

The 2025 annual report reveals a challenging financial year for AMN Healthcare, marked by a second consecutive net loss and substantial non-cash impairment charges. Revenue declined by 8% year-over-year to $2.73 billion, primarily due to reduced demand in the nurse and allied solutions segment. The $109.5 million goodwill impairment in the physician and leadership solutions segment, following a $222.5 million impairment in 2024, indicates persistent underperformance of acquired assets and raises concerns about the company's long-term growth strategy and asset valuations. While the net loss narrowed from $147.0 million in 2024, the continued unprofitability and additional $18.3 million impairment of intangible assets signal ongoing pressures. The company successfully refinanced $500 million in senior notes, but the new 2031 notes carry a higher interest rate, which could impact future profitability. Investors should monitor the company's ability to reverse revenue declines, improve profitability, and demonstrate the value of its remaining goodwill and intangible assets. The high customer concentration with Kaiser Foundation Hospitals (22% of revenue) also presents a notable risk.

At the time of this filing, AMN was trading at $17.85 on NYSE in the Trade & Services sector, with a market capitalization of approximately $663.8M. The 52-week trading range was $14.87 to $30.49. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed AMN - Latest Insights

AMN
Mar 18, 2026, 8:00 AM EDT
Filing Type: DEF 14A
Importance Score:
8
AMN
Feb 19, 2026, 6:15 PM EST
Filing Type: 10-K
Importance Score:
8
AMN
Feb 19, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
AMN
Jan 14, 2026, 9:01 AM EST
Filing Type: 8-K
Importance Score:
7